Physician profile
Paul E Battles
NPI 1568485589
$2,306.93
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,008 · 2020: $124 · 2022: $1,052 · 2023: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $455.61 | 2019-2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $282.69 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $216.19 | 2019-2023 | |
| Astellas Pharma US INC | $186.52 | 2019-2022 | |
| Lilly USA, LLC | $178.21 | 2019-2022 | |
| Pfizer INC. | $160.58 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.22 | 2019-2022 | |
| Abbvie INC. | $90.51 | 2022 | |
| Novartis Pharmaceuticals Corporation | $87.48 | 2019-2022 | |
| Glaxosmithkline, LLC. | $85.87 | 2019-2020 | |
| Amgen INC. | $67.55 | 2022 | |
| Merck Sharp & Dohme LLC | $67.15 | 2019-2022 | |
| Abbott Laboratories | $51.34 | 2022-2023 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $47.11 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $43.12 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $43.03 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.20 | 2020-2022 | |
| Amarin Pharma, INC. | $36.04 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.93 | 2022 | |
| Nabriva Therapeutics, Plc | $16.54 | 2022 | |
| Mylan Specialty L.P. | $14.81 | 2019 | |
| Exact Sciences Corporation | $14.08 | 2023 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Battles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.